Fidelity Investments’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8K | Sell |
13,446
-29,620
| -69% | -$63.4K | ﹤0.01% | 4139 |
|
|
2025
Q1 | $49.5K | Buy |
43,066
+5,943
| +16% | +$6.83K | ﹤0.01% | 3865 |
|
|
2024
Q4 | $81.3K | Sell |
37,123
-93,763
| -72% | -$205K | ﹤0.01% | 3638 |
|
|
2024
Q3 | $285K | Buy |
130,886
+3,854
| +3% | +$8.4K | ﹤0.01% | 3070 |
|
|
2024
Q2 | $293K | Sell |
127,032
-251,589
| -66% | -$581K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $2.08M | Buy |
378,621
+309,138
| +445% | +$1.7M | ﹤0.01% | 2324 |
|
|
2023
Q4 | $172K | Sell |
69,483
-8,608,046
| -99% | -$21.3M | ﹤0.01% | 3009 |
|
|
2023
Q3 | $301M | Buy |
8,677,529
+124,298
| +1% | +$4.32M | 0.03% | 553 |
|
|
2023
Q2 | $281M | Buy |
8,553,231
+948,890
| +12% | +$31.1M | 0.02% | 597 |
|
|
2023
Q1 | $255M | Buy |
7,604,341
+5,909,854
| +349% | +$198M | 0.02% | 617 |
|
|
2022
Q4 | $55.6M | Sell |
1,694,487
-201,325
| -11% | -$6.6M | 0.01% | 1215 |
|
|
2022
Q3 | $65.4M | Buy |
1,895,812
+319,870
| +20% | +$11M | 0.01% | 1134 |
|
|
2022
Q2 | $19.3M | Buy |
1,575,942
+758,903
| +93% | +$9.28M | ﹤0.01% | 1663 |
|
|
2022
Q1 | $11.1M | Buy |
817,039
+3,367
| +0.4% | +$45.7K | ﹤0.01% | 2076 |
|
|
2021
Q4 | $16.2M | Buy |
+813,672
| New | +$16.2M | ﹤0.01% | 1919 |
|